Catheter Precision
VTAK
VTAK was delisted on the 2nd of October, 2026.
13 hedge funds and large institutions have $74.2M invested in Catheter Precision in 2018 Q3 according to their latest regulatory filings, with 13 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
30.95% more ownership
Funds ownership: 0% → 30.95% (+31%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$4.54M |
| 2 |
BAMCO Inc
New York
|
+$4.54M |
| 3 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
+$4.54M |
| 4 |
DM
Deerfield Management
New York
|
+$4.54M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$4.54M |
Top Sellers
VTAK Hedge Fund Activity: Q3 2018 in Review
13 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Catheter Precision (VTAK) for Q3 2018, worth a combined $74.2M.
Buyers outnumbered sellers: 13 funds opened new VTAK positions and 0 closed out — a net gain of 13 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was ArrowMark Colorado Holdings, opening a new position worth an estimated $4.54M.
- 13 institutional investors held Catheter Precision (VTAK) as of Q3 2018, up from 0 in Q2 2018.
- Funds reported $74.2M of Catheter Precision stock for Q3 2018.
- 13 funds opened new Catheter Precision positions in Q3 2018 and 0 closed out, a net change of +13 holders.
- The largest Catheter Precision buyer in Q3 2018 was ArrowMark Colorado Holdings, an estimated $4.54M added.
Based on aggregated 13F filings for Q3 2018.